"Unexpected high placebo response" scuttles anothe
Post# of 148288
Amazing how this seems to happen so often to SMALLER biotechs, but not to Big Pharma.
Quote:
https://www.fiercebiotech.com/biotech/pharnex...-3-failure
The 387-patient trial did not show that the drug was able to improve functional motor disability as measured by the Overall Neuropathy Limitation Scale (ONLS), the company revealed in a Dec. 11 release. Pharnext blamed an “unexpected” improvement in the disease among the placebo cohort, which it said “complicates the interpretation of the results.”